Concealed Inherited Cardiomyopathies Detected in Cardio-Oncology Screening.

ABSTRACT:

Introduction

Basal cardiovascular risk assessment in cardio-oncology is essential. Integrating clinical information, ECG and transthoracic echocardiogram can identify concealed inherited cardiomyopathies (ICMPs) with potential added risk of cardiotoxicity. We aimed to evaluate the impact of our Cardio-Oncology Unit design in detecting concealed ICMPs.

Methods

We carried out a retrospective study of all consecutive breast cancer patients referred to the Cardio-Oncology Unit for cardiac evaluation (2020-2022). ICMPs diagnosis was provided according to ESC guidelines and underwent genetic testing. ICMPs prevalence in this cohort was compared to the highest and lowest frequency reported in the general population.

Results

Among 591 breast cancer patients, we identified eig

SUBMITTER: Lorca R 

PROVIDER: S-EPMC10780282 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature